SCHEMBL9367334

SCHEMBL9367334

CC(C)(C(=O)c1cccs1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.52
HPGDS O60760 1/20 0.50
KMT2A Q03164 4/20 0.48
MAPT P10636 2/20 0.48
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
TSHR P16473 1/20 0.46
LMNA P02545 2/20 0.46
ALOX15 P16050 1/20 0.46
ALOX5 P09917 1/20 0.45
PTGS1 P23219 1/20 0.45
PTGS2 P35354 1/20 0.45
RAB9A P51151 3/20 0.45
MEN1 O00255 3/20 0.44
ALDH1A1 P00352 3/20 0.44
NPC1 O15118 2/20 0.44
POLB P06746 1/20 0.44
HDAC1 Q13547 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12260664 0.86 NPC1 (0.54) DAOKMT2AMAPTCES2CES1
SCHEMBL31497793 0.83 DAO (0.48) DAOHPGDSKMT2AMAPTCES2
SCHEMBL3732383 0.79 CES2 (0.58) DAOHPGDSKMT2AMAPTCES2
SCHEMBL3181932 0.79 CES2 (0.58) DAOHPGDSKMT2ACES2CES1
SCHEMBL15120382 0.77 CES2 (0.56) DAOHPGDSKMT2ACES2CES1
SCHEMBL5394296 0.74 CES2 (0.62) DAOHPGDSKMT2ACES2CES1
SCHEMBL7351536 0.74 DAO (0.50) DAOHPGDSKMT2AMAPTCES2
SCHEMBL11701235 0.73 HPGDS (0.62) DAOHPGDSMAPTCES2CES1
SCHEMBL3196141 0.73 TSHR (0.51) DAOHPGDSKMT2AMAPTCES2
SCHEMBL17204107 0.73 CES2 (0.50) DAOHPGDSKMT2AMAPTCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0346791-B1 1,2-diarylethylamines for treatment of neurotoxic injury SEARLE & CO (US) 1994-04-06 EP disclosed
EP-0346791-A1 1,2-diarylethylamines for treatment of neurotoxic injury G.D. Searle & Co. (US) 1989-12-20 EP disclosed